Systematic Review of Efficacy and Safety of Agomelatine in the Treatment of Patients with Depression and Sleep Disorders

GUO Fei; HUANG Yunhui; DU Ailing; NIU Huifang; HUANG Yujing; WEI Bo; ZHAO Yifan; DONG Jinjin; YUE Kaichen; ZHAO Zhekun; WANG Lingjun; YANG Shichang

doi:10.14009/j.issn.1672-2124.2021.02.017

您当前的位置：

首页 >

文章列表页 >

Systematic Review of Efficacy and Safety of Agomelatine in the Treatment of Patients with Depression and Sleep Disorders

更新时间：2022-10-08

- Systematic Review of Efficacy and Safety of Agomelatine in the Treatment of Patients with Depression and Sleep Disorders
- Vol. 21, Issue 2, Pages: 195-198(2021)
- 作者机构：
  
  1. 新乡医学院第二附属医院药学部
  2. 新乡市第一人民医院风湿免疫科
  3. 新乡医学院第二附属医院神经内科
  4. 新乡医学院药学院
  5. 新乡医学院第二附属医院精神科
- 作者简介：
- 基金信息：
- DOI：10.14009/j.issn.1672-2124.2021.02.017
  CLC： R740;R749.4
- Published：2021，
扫描看全文
[1]郭飞,黄云慧,杜爱玲,牛慧芳,黄宇靖,卫博,赵奕帆,董锦锦,岳恺晨,赵喆堃,王领军,杨世昌.阿戈美拉汀治疗抑郁症伴睡眠障碍的疗效和安全性的系统评价[J].中国医院用药评价与分析,2021,21(02):195-198+203.

GUO Fei, HUANG Yunhui, DU Ailing, et al. Systematic Review of Efficacy and Safety of Agomelatine in the Treatment of Patients with Depression and Sleep Disorders. [J]. 21(2):195-198(2021)
[1]郭飞,黄云慧,杜爱玲,牛慧芳,黄宇靖,卫博,赵奕帆,董锦锦,岳恺晨,赵喆堃,王领军,杨世昌.阿戈美拉汀治疗抑郁症伴睡眠障碍的疗效和安全性的系统评价[J].中国医院用药评价与分析,2021,21(02):195-198+203. DOI： 10.14009/j.issn.1672-2124.2021.02.017.

GUO Fei, HUANG Yunhui, DU Ailing, et al. Systematic Review of Efficacy and Safety of Agomelatine in the Treatment of Patients with Depression and Sleep Disorders. [J]. 21(2):195-198(2021) DOI： 10.14009/j.issn.1672-2124.2021.02.017.

摘要

目的:基于荟萃分析（Meta分析）方法

系统评价阿戈美拉汀对抑郁症伴睡眠障碍患者的睡眠改善效果及其安全性

为临床治疗提供循证参考。方法:检索PubMed、the Cochrane Library、EMBase、中国知网、万方数据库和维普数据库

纳入从建库至2020年4月公开发表的关于阿戈美拉汀治疗抑郁症伴睡眠障碍患者的中英文文献[研究组患者单独使用阿戈美拉汀口服治疗

对照组患者单独使用5-羟色胺再摄取抑制类抗抑郁药（米氮平、帕罗西汀或艾司西酞普兰等）治疗或阿戈美拉汀联合其他药物治疗]

提取汉密尔顿抑郁量表（Hamilton depression scale

HAMD）评分和匹茨堡睡眠质量指数（Pittsburgh sleep quality index

PSQI）相关数据

采用Rev Man 5.3软件进行文献质量评价和Meta分析。结果:共纳入8项研究

合计332例患者。Meta分析结果显示

抑郁症伴睡眠障碍患者单独使用阿戈美拉汀治疗后

其HAMD评分（SMD=-5.31

95%CI=-6.28～-4.33

P<0.000 01）、PSQI总分（SMD=-3.66

95%CI=-4.16～-3.17

P<0.000 01）均较治疗前明显降低

差异均有统计学意义。结论:阿戈美拉汀对抑郁症伴睡眠障碍患者的抑郁症状和失眠症状均有较好的改善作用

但受纳入研究的质量和样本量限制

该结论需大样本、多中心、长时间的随访结果进行验证。

Abstract

OBJECTIVE: To systematically evaluate the improvement effect and safety of agomelatine in patients with depression and sleep disorders based on the Meta-analysis method

so as to provide evidence-based reference for clinical treatment.METHODS: PubMed

the Cochrane Library

EMBase

CNKI

Wanfang database and VIP database were retrieved to collect the Chinese and English literature of agomelatine in the treatment of patients with depression and sleep disorders published from the establishment of the database to Apr. 2020. The study group was treated with agomelatine alone

while the control group received serotonin reuptake inhibitor antidepressants（ mirtazapine

paroxetine or escitalopram） alone or agomelatine in combination with other medications. Hamilton Depression Scale（ HAMD） score and Pittsburgh Sleep Quality Index（ PSQI） were extracted

and RevMan 5. 3 software was used for literature quality evaluation and Meta-analysis. RESULTS: Totally 8 literature were collected

including 332 patients.Meta-analysis results showed that the HAMD score（ SMD =-5. 31

95% CI =-6. 28--4. 33

P < 0. 000 01） and PSQI total score（ SMD =-3. 66

95%CI =-4. 16--3. 17

P <0. 000 01） of patients with depression and sleep disorders with treatment of agomelatine alone were significantly lower than those before treatment

with statistically significant difference. CONCLUSIONS: The improvement of agomelatine in patients with depression and sleep disorders is significant.However

due to the limitation of the quality and sample size of the included studies

the conclusion needs to be verified by the results of large sample

multi-center and long-term follow-up.

关键词

抑郁症失眠睡眠障碍阿戈美拉汀Meta分析

Keywords

DepressionInsomniaSleep disordersAgomelatineMeta-analysis

references

查看原文

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Systematic Review of Efficacy and Safety of Dantian Jiangzhi Pills Combined with Statins in the Treatment of Hyperlipidemia

Systematic Review of Huisheng Oral Liquid on Coagulation Function, Efficacy and Safety of Patients with Non-Small Cell Lung Cancer

Systematic Review of Clinical Efficacy and Safety of Formula Granules of Liangfu Pill in the Treatment of Epigastric Pain

Systematic Review of Runzao Zhiyang Capsules Combined with Antihistamine in the Treatment of Chronic Urticaria

Meta-Analysis of Efficacy and Safety of Ticagrelor Combined with Rosuvastatin Therapy in the Treatment of Unstable Angina Pectoris

Related Author

LIU Wei

LI Xingxing

FAN Zongjing

CUI Jie

WU Yang

ZHANG Jinhua

TIAN Yuan

YANG Xiaoping

Related Institution

Second School of Clinical Medicine, Beijing University of Chinese Medicine

Dept.of Cardiology, Dongfang Hospital, Beijing University of Chinese Medicine

Dept. of Oncology, Jingmen First People’s Hospital

Traditional Chinese Medicine Phenomics Research Center, Traditional Chinese Medicine Hospital Affiliated to Southwest Medical University

Dept. of Internal Medicine of Traditional Chinese Medicine, Shanghai Seventh People’s Hospital

⁰